Global and Russian trends in Maternal mortality

Filippov O.S.; Guseva E.V.; Pavlov K.D.

doi:https://doi.org/10.17116/repro202430011100

Close metadata

Recommended articles:

Molecular mechanisms of preeclampsia. Russian Journal of Human Reproduction. 2025;(2):44-53

The level of hypoxia-induced factor-1a and associated molecules in preeclampsia. Russian Bulletin of Obstetrician-Gynecologist. 2025;(1):5-10

Modern concepts of preeclampsia, taking into account the role of the permeability of the hematoencephalic barrier. Russian Bulletin of Obstetrician-Gynecologist. 2025;(1):11-18

Prevalence of periodontal disease among adolescents in the Nenets autonomous area. Stomatology. 2025;(1):57-62

Intraoperative left ventricular rupture in cardiac surgery. Pirogov Russian Journal of Surgery. 2025;(4):95-99

Frailty in patients with atrial fibrillation: diagnosis, management, prevention and influence on prognosis. Russian Cardiology Bulletin. 2025;(1):5-12

Morphological markers of mitochondrial dysfunction of the basal plate cytotrophoblast of the placenta in preeclampsia of varying severity. Russian Journal of Archive of Pathology. 2025;(2):24-29

The role of some markers of the infectious process in the early diagnosis and evaluation of the effectiveness of antibiotic therapy in obstetric sepsis. Russian Bulletin of Obstetrician-Gynecologist. 2025;(2):15-20

Treatment and prevention of suture failure and bleeding after various bariatric interventions. Pirogov Russian Journal of Surgery. 2025;(5):79-85

Prognostic model of a patient with sepsis readiness to early mobilization with assistance. Problems of Balneology, Physiotherapy and Exercise Therapy. 2025;(2):26-26

Abstract:

The maternal mortality (MM) rate is a universal indicator of the level of social wellbeing, quality and accessibility of medical care for women during pregnancy, labor and in the postpartum period, which characterizes the state of health and society generally.The authors of the article analyzed trends in the ratio and structure of MM in the period from 1990 to 2021 in the world (according to the data of WHO) and in the Russian Federation (according to the data of Heath Ministry of Russia), assessed the significance of the direct obstetric causes in the dynamics of the rate and structure of MM. In 2020, compared to 2015, 17 countries recorded an increase in the level of MM. Among them is Russia. The MM indicator in the Russian Federation according to the Russian Ministry of Health in 2020 increased by 52.3% compared to 2015 and amounted to 16.3 per 100.000 live births. The first place in the structure of MM was taken by extragenital diseases (71.4%), the second — septic complications (8.1%), the third — bleeding (6.4%). The growth of MM occurs against the background of the growth of critical obstetric conditions caused by direct obstetric causes. In 2021, the increase in the number of MM cases after abortions is noteworthy: twice as compared to 2017 and 1.6 times as compared to 2020. The leading causes of MM in early pregnancy are extragenital diseases, sepsis and bleeding. Taking into account the analytical information presented in the article, today it is impossible to recognize the MM problem as solved. In 2019, the historical minimum of the MM rate was observed in the Russian Federation, which is a confirmation of the potential of Russian Federation for the successful implementation of the United Nations Millennium Declaration in terms of eliminating preventable cases of MM.

Keywords:

maternal mortality

near miss

preeclampsia

sepsis

bleeding

united nations

World Health Organization

Authors:

Filippov O.S.

Federal Scientific and Clinical Center for Children and Adolescents of the Federal Medical and Biological Agency of Russia;
Russian University of Medicine

ORCID: 0000-0003-2654-1334

Guseva E.V.

National Medical Research Center for Obstetrics, Gynecology and Perinatology named after Academician V.I. Kulakov

ORCID: 0000-0002-7480-9625

Pavlov K.D.

Federal Scientific and Clinical Center for Children and Adolescents of the Federal Medical and Biological Agency of Russia

ORCID: 0000-0003-4964-4221

Received:

31.10.2023

Accepted:

08.11.2023

Close metadata

References:

Trends in Maternal Mortality: 1990 to 2015. World Health Organization, 2016. Accessed December 12, 2023. https://openknowledge.worldbank.org/entities/publication/b01d9c8a-9113-50e2-9393-4c39e8c0b749
Materinskaya smertnost’ v Rossijskoj Federacii v 2015 g. (metodicheskoe pis’mo). Ministerstvo zdravoohraneniya Rossijskoj Federacii, 2016. (In Russ.).
Trends in maternal mortality 2000 to 2020: estimates by WHO, UNICEF, UNFPA, World Bank Group and UNDESA/Population Division. Executive summary. World Health Organization, 2023. Accessed December 12, 2023. https://www.who.int/publications/i/item/9789240068759
Filippov OS, Guseva EV. Maternal mortality in the Russian Federation in 2020: the first year of the pandemic. Problemy reprodukcii. 2022;28(1):8-28. (In Russ.). https://doi.org/10.17116/repro2022280118
Oficial’nyj sajt Vsemirnoj organizacii zdravoohraneniya. Informacionnyj byulleten’ «Materinskaya smertnost’». 2023. (In Russ.). https://www.who.int/ru/news-room/fact-sheets/detail/maternal-mortality
Filippov OS, Guseva EV. Maternal mortality in the Russian Federation in 2019. Problemy reprodukcii. 2020;26(6-2):8-26. (In Russ.). https://doi.org/10.17116/repro2020260628

Braems G, Denys H, De Wever O, Cocquyt V, Van den Broecke R. Use of tamoxifen before and during pregnancy. The Oncologist. 2011;16(11):1547-51. https://doi.org/10.1634/theoncologist.2011-0121

Egashira K, Hiasa K, Yokota N, Kawamura T, Matsushita T, Okugawa K, Yahata H, Sonoda K, Kato K. Infertility after abdominal trachelectomy. Acta Obstetricia et Gynecologica Scandinavica. 2018; 97(11):1358-1364. https://doi.org/10.1111/aogs.13429

Schimberni M, Morgia F, Colabianchi J, Giallonardo A, Piscitelli C, Giannini P, Montigiani M, Sbracia M. Natural-cycle in vitro fertilization in poor responder patients: a survey of 500 consecutive cycles. Fertility and Sterility. 2009;92(4):1297-1301. https://doi.org/10.1016/j.fertnstert.2008.07.1765

De Marco MP, Montanari G, Ruscito I, Giallonardo A, Ubaldi FM, Rienzi L, Costanzi F, Caserta D, Schimberni M, Schimberni M. Natural Cycle Results in Lower Implantation Failure than Ovarian Stimulation in Advanced-Age Poor Responders Undergoing IVF: Fertility Outcomes from 585 Patients. Reproductive Sciences. 2021; 28(7):1967-1973. https://doi.org/10.1007/s43032-020-00455-5

Chan JL, Johnson LN, Efymow BL, Sammel MD, Gracia CR. Outcomes of ovarian stimulation after treatment with chemotherapy. Journal of Assisted Reproduction and Genetics. 2015;32(10):1537-1545. https://doi.org/10.1007/s10815-015-0575-2

Checa Vizcaíno MA, Corchado AR, Cuadri ME, Comadran MG, Brassesco M, Carreras R. The effects of letrozole on ovarian stimulation for fertility preservation in cancer-affected women. Reproductive Biomedicine Online. 2012;24(6):606-610. https://doi.org/10.1016/j.rbmo.2012.02.020

Oktay K, Türkçüoğlu I, Rodriguez-Wallberg KA. GnRH agonist trigger for women with breast cancer undergoing fertility preservation by aromatase inhibitor/FSH stimulation. Reproductive Biomedicine Online. 2010;20(6):783-788. https://doi.org/10.1016/j.rbmo.2010.03.004

Azim AA, Costantini-Ferrando M, Oktay K. Safety of fertility preservation by ovarian stimulation with letrozole and gonadotropins in patients with breast cancer: a prospective controlled study. Journal of Clinical Oncology. 2008;26(16):2630-2635. https://doi.org/10.1200/JCO.2007.14.8700

Turan V, Bedoschi G, Moy F, Oktay K. Safety and feasibility of performing two consecutive ovarian stimulation cycles with the use of letrozole-gonadotropin protocol for fertility preservation in breast cancer patients. Fertility and Sterility. 2013;100(6):1681-5.e1. https://doi.org/10.1016/j.fertnstert.2013.08.030

Rosenberg E, Fredriksson A, Einbeigi Z, Bergh C, Strandell A. No increased risk of relapse of breast cancer for women who give birth after assisted conception. Human Reproduction Open. 2019;(4): hoz039. https://doi.org/10.1093/hropen/hoz039

Sonigo C, Sermondade N, Calvo J, Benard J, Sifer C, Grynberg M. Impact of letrozole supplementation during ovarian stimulation for fertility preservation in breast cancer patients. European Journal of Obstetrics and Gynecology and Reproductive Biology. 2019;4:100049. https://doi.org/10.1016/j.eurox.2019.100049

Bonardi B, Massarotti C, Bruzzone M, Goldrat O, Mangili G, Anserini P, Spinaci S, Arecco L, Del Mastro L, Ceppi M, Demeestere I, Lambertini M. Efficacy and Safety of Controlled Ovarian Stimulation With or Without Letrozole Co-administration for Fertility Preservation: A Systematic Review and Meta-Analysis. Frontiers in Oncology. 2020;10:574669. https://doi.org/10.3389/fonc.2020.574669

Chian RC, Buckett WM, Tulandi T, Tan SL. Prospective randomized study of human chorionic gonadotrophin priming before immature oocyte retrieval from unstimulated women with polycystic ovarian syndrome. Human Reproduction. 2000;15(1):165-170. https://doi.org/10.1093/humrep/15.1.165

Holzer H, Scharf E, Chian RC, Demirtas E, Buckett W, Tan SL. In vitro maturation of oocytes collected from unstimulated ovaries for oocyte donation. Fertility and Sterility. 2007;88(1):62-67. https://doi.org/10.1016/j.fertnstert.2006.11.087

Kedem A, Yerushalmi GM, Brengauz M, Raanani H, Orvieto R, Hourvitz A, Meirow D. Outcome of immature oocytes collection of 119 cancer patients during ovarian tissue harvesting for fertility preservation. Journal of Assisted Reproduction and Genetics. 2018;35(5): 851-856. https://doi.org/10.1007/s10815-018-1153-1

Park CW, Lee SH, Yang KM, Lee IH, Lim KT, Lee KH, Kim TJ. Cryopreservation of in vitro matured oocytes after ex vivo oocyte retrieval from gynecologic cancer patients undergoing radical surgery. Clinical and Experimental Reproductive Medicine. 2016;43(2):119-125. https://doi.org/10.5653/cerm.2016.43.2.119

Kawamura K, Cheng Y, Kawamura N, Takae S, Okada A, Kawagoe Y, Mulders S, Terada Y, Hsueh AJ. Pre-ovulatory LH/hCG surge decreases C-type natriuretic peptide secretion by ovarian granulosa cells to promote meiotic resumption of pre-ovulatory oocytes. Human Reproduction. 2011;26(11):3094-3101. https://doi.org/10.1093/humrep/der282

Mohsenzadeh M, Khalili MA, Tabibnejad N, Yari N, Agha-Rahimi A, Karimi-Zarchi M. Embryo Cryopreservation Following In-Vitro Maturation for Fertility Preservation in a Woman with Mullerian Adenosarcoma: A Case Report. Journal of Human Reproductive Sciences. 2017;10(2):138-141. https://doi.org/10.4103/jhrs.JHRS_93_16

Kirillova A, Bunyaeva E, Van Ranst H, Khabas G, Farmakovskaya M, Kamaletdinov N, Nazarenko T, Abubakirov A, Sukhikh G, Smitz JEJ. Improved maturation competence of ovarian tissue oocytes using a biphasic in vitro maturation system for patients with gynecological malignancy: a study on sibling oocytes. Journal of Assisted Reproduction and Genetics. 2021;38(6):1331-1340. https://doi.org/10.1007/s10815-021-02118-z

Sanchez F, Le AH, Ho VNA, Romero S, Van Ranst H, De Vos M, Gilchrist RB, Ho TM, Vuong LN, Smitz J. Biphasic in vitro maturation (CAPA-IVM) specifically improves the developmental capacity of oocytes from small antral follicles. Journal of Assisted Reproduction and Genetics. 2019;36(10):2135-2144. https://doi.org/10.1007/s10815-019-01551-5

De Roo C, Tilleman K. In Vitro Maturation of Oocytes Retrieved from Ovarian Tissue: Outcomes from Current Approaches and Future Perspectives. Journal of Clinical Medicine. 2021;10(20):4680. https://doi.org/10.3390/jcm10204680

Dinikina YuV, Belogurova MB, Govorov IE, Gamzatova ZKh, Pervunina TM, Komlichenko EV. Cryopreservation of ovarian tissue in girls with oncological diseases: a multidisciplinary approach. Rossijskij zhurnal detskoj gematologii i onkologii. 2019;6(3):59-67. https://doi.org/10.21682/2311-1267-2019-6-3-59-67

Abakushina EV, Otoi T, Kaprin AD. Recovery options of reproductive function of cancer patients due to transplantation of cryopreserved ovarian tissue. Geny i kletki. 2015;10(1):18-27. (In Russ.).

Gougeon A, Chainy GB. Morphometric studies of small follicles in ovaries of women at different ages. Journal of Reproduction and Fertility. 1987;81(2):433-442. https://doi.org/10.1530/jrf.0.0810433

Dolmans MM, von Wolff M, Poirot C, Diaz-Garcia C, Cacciottola L, Boissel N, Liebenthron J, Pellicer A, Donnez J, Andersen CY. Transplantation of cryopreserved ovarian tissue in a series of 285 women: a review of five leading European centers. Fertility and Sterility. 2021;115(5):1102-1115. https://doi.org/10.1016/j.fertnstert.2021.03.008

Donnez J, Dolmans MM. Ovarian cortex transplantation: 60 reported live births brings the success and worldwide expansion of the technique towards routine clinical practice. Journal of Assisted Reproduction and Genetics. 2015;32(8):1167-1170. https://doi.org/10.1007/s10815-015-0544-9

Roness H, Meirow D. Fertility preservation: Follicle reserve loss in ovarian tissue transplantation. Reproduction. 2019;158(5):F35-F44. https://doi.org/10.1530/REP-19-0097

Nisolle M, Casanas-Roux F, Qu J, Motta P, Donnez J. Histologic and ultrastructural evaluation of fresh and frozen-thawed human ovarian xenografts in nude mice. Fertility and Sterility. 2000;74(1): 122-129. https://doi.org/10.1016/s0015-0282(00)00548-3

Tanaka A, Nakamura H, Tabata Y, Fujimori Y, Kumasawa K, Kimura T. Effect of sustained release of basic fibroblast growth factor using biodegradable gelatin hydrogels on frozen-thawed human ovarian tissue in a xenograft model. The Journal of Obstetrics and Gynaecology Research. 2018;44(10):1947-1955. https://doi.org/10.1111/jog.13726

Wallace WH, Kelsey TW. Human ovarian reserve from conception to the menopause. PLoS One. 2010;5(1):e8772. https://doi.org/10.1371/journal.pone.0008772

Dolmans MM, Marinescu C, Saussoy P, Van Langendonckt A, Amorim C, Donnez J. Reimplantation of cryopreserved ovarian tissue from patients with acute lymphoblastic leukemia is potentially unsafe. Blood. 2010;116(16):2908-2914. https://doi.org/10.1182/blood-2010-01-265751

Diaz-Garcia C, Domingo J, Garcia-Velasco JA, Herraiz S, Mirabet V, Iniesta I, Cobo A, Remohí J, Pellicer A. Oocyte vitrification versus ovarian cortex transplantation in fertility preservation for adult women undergoing gonadotoxic treatments: a prospective cohort study. Fertility and Sterility. 2018;109(3):478-485.e2. https://doi.org/10.1016/j.fertnstert.2017.11.018

Arvold ND, Taghian AG, Niemierko A, Abi Raad RF, Sreedhara M, Nguyen PL, Bellon JR, Wong JS, Smith BL, Harris JR. Age, breast cancer subtype approximation, and local recurrence after breast-conserving therapy. Journal of Clinical Oncology. 2011;29(29): 3885-3891. https://doi.org/10.1200/JCO.2011.36.1105

Gellert SE, Pors SE, Kristensen SG, Bay-Bjørn AM, Ernst E, Yding Andersen C. Transplantation of frozen-thawed ovarian tissue: an update on worldwide activity published in peer-reviewed papers and on the Danish cohort. Journal of Assisted Reproduction and Genetics. 2018;35(4):561-570. https://doi.org/10.1007/s10815-018-1144-2

Salim N, Tumanova K, Stolbovoy A, Zvereva D, Popodko A Nosov V. Adaptive VMAT Radiotherapy to Avoid Brachytherapy in Cervical Cancer Treatment. International Journal of Radiation Oncology and Biology and Physics. 2022;114(supp 3):e262.

Bystrova O, Lapina E, Kalugina A, Lisyanskaya A, Tapilskaya N, Manikhas G. Heterotopic transplantation of cryopreserved ovarian tissue in cancer patients: a case series. Gynecological Endocrinology. 2019;35(12):1043-1049. https://doi.org/10.1080/09513590.2019.1648413

Donnez J. Chemotherapy and decline of the ovarian reserve: How can we explain it and how to prevent it? Fertility and Sterility. 2020; 114(4):722-724. https://doi.org/10.1016/j.fertnstert.2020.08.010

ESHRE Guideline Group on Female Fertility Preservation; Anderson RA, Amant F, Braat D, D’Angelo A, Chuva de Sousa Lopes SM, Demeestere I, Dwek S, Frith L, Lambertini M, Maslin C, Moura-Ramos M, Nogueira D, Rodriguez-Wallberg K, Vermeulen N. ESHRE guideline: female fertility preservation. Human Reproduction Open. 2020;2020(4):hoaa052. https://doi.org/10.1093/hropen/hoaa052

Kindinger LM, Kyrgiou M, MacIntyre DA, Cacciatore S, Yulia A, Cook J, Terzidou V, Teoh TG, Bennett PR. Preterm Birth Prevention Post-Conization: A Model of Cervical Length Screening with Targeted Cerclage. PLoS One. 2016;11(11):e0163793. https://doi.org/10.1371/journal.pone.0163793

Kyrgiou M, Athanasiou A, Paraskevaidi M, Mitra A, Kalliala I, Martin-Hirsch P, Arbyn M, Bennett P, Paraskevaidis E. Adverse obstetric outcomes after local treatment for cervical preinvasive and early invasive disease according to cone depth: systematic review and meta-analysis. BMJ. 2016;354:i3633. https://doi.org/10.1136/bmj.i3633

Li X, Li J, Wu X. Incidence, risk factors and treatment of cervical stenosis after radical trachelectomy: A systematic review. European Journal of Cancer. 2015;51(13):1751-1759. https://doi.org/10.1016/j.ejca.2015.05.012

Kasuga Y, Ikenoue S, Tanaka M, Ochiai D. Management of pregnancy after radical trachelectomy. Gynecological Oncology. 2021; 162(1):220-225. https://doi.org/10.1016/j.ygyno.2021.04.023

Šimják P, Cibula D, Pařízek A, Sláma J. Management of pregnancy after fertility-sparing surgery for cervical cancer. Acta Obstetricia et Gynecologica Scandinavia. 2020;99(7):830-838. https://doi.org/10.1111/aogs.13917

Sato Y, Hidaka N, Sakai A, Kido S, Fujita Y, Okugawa K, Yahata H, Kato K. Evaluation of the efficacy of vaginal progesterone in preventing preterm birth after abdominal trachelectomy. European Journal of Obstetrics Gynecology and Reproducive Biology. 2021;259: 119-124. https://doi.org/10.1016/j.ejogrb.2021.02.009

Signorello LB, Cohen SS, Bosetti C, Stovall M, Kasper CE, Weathers RE, Whitton JA, Green DM, Donaldson SS, Mertens AC, Robison LL, Boice JD Jr. Female survivors of childhood cancer: preterm birth and low birth weight among their children. Journal of National Cancer Institute. 2006;98(20):1453-1461. https://doi.org/10.1093/jnci/djj394

Schumer ST, Cannistra SA. Granulosa cell tumor of the ovary. Journal of Clinical Oncology. 2003;21(6):1180-1189. https://doi.org/10.1200/JCO.2003.10.019

Spanos CP, Mamopoulos A, Tsapas A, Syrakos T, Kiskinis D. Female fertility and colorectal cancer. International Journal of Colorectal Diseases. 2008;23(8):735-743. https://doi.org/10.1007/s00384-008-0483-3

Lopategui DM, Yechieli R, Ramasamy R. Oncofertility in sarcoma patients. Translational Andrology and Urology. 2017;6(5):951-958. https://doi.org/10.21037/tau.2017.07.03

Practice Committees of the American Society for Reproductive Medicine and the Society for Assisted Reproductive Technology. Mature oocyte cryopreservation: a guideline. Fertility and Sterility. 2013;99(1):37-43. https://doi.org/10.1016/j.fertnstert.2012.09.028

Akhmedova ZB, Umarova SG, Ashurova MJ. Fertility and Hodgkin’s lymphoma. Vestnik Avicennyt. 2013;(2):167-172. (In Russ.).

Hodgson DC, Pintilie M, Gitterman L, Dewitt B, Buckley CA, Ahmed S, Smith K, Schwartz A, Tsang RW, Crump M, Wells W, Sun A, Gospodarowicz MK. Fertility among female hodgkin lymphoma survivors attempting pregnancy following ABVD chemotherapy. Hematological Oncology. 2007;25(1):11-15. https://doi.org/10.1002/hon.802

Watson M, Wheatley K, Harrison GA, Zittoun R, Gray RG, Goldstone AH, Burnett AK. Severe adverse impact on sexual functioning and fertility of bone marrow transplantation, either allogeneic or autologous, compared with consolidation chemotherapy alone: analysis of the MRC AML 10 trial. Cancer. 1999;86(7):1231-1239. https://doi.org/10.1002/(sici)1097-0142(19991001)86:7<1231::aid-cncr18>3.0.co;2-y